Come up with a name for your new list and we'll add to it:
AvidBiotics raised a round of funding on October 25, 2010. Investors include
National Institutes of Health.
AvidBiotics is a developer of non-antibody proteins as targeted therapeutics against bacteria, viral infections and cancers. The scaffolds of AvidBiotics' proteins exhibit functional potency, e.g. kil…